Premier Alternatives

Resilience (Blue Ash)

Blue Ash, OH · Founded 2020 · Privately Held (backing)

Operator of a biopharmaceutical manufacturing company intended to change the way medicine is produced. Resilience (Blue Ash) is based in Blue Ash, OH and was founded in 2020. Its last reported valuation was $9.4 billion in Jan 2023. It has raised $3.3 billion.

Last reported valuation
$9.4B
Oct 2026
Priced at
—
Total raised
$3.3B
Last round
—

Resilience (Blue Ash) key facts

as of Oct 2026
  • Operator of a biopharmaceutical manufacturing company intended to change the way medicine is produced.
  • Resilience (Blue Ash) is valued at approximately $9.4B as of Oct 2026 (last reported valuation).
  • It has raised $3.3B; the latest was General Corporate Purpose ($867.4M) in Oct 2025.
  • Notable investors include Mubadala Investment Company, GV, 8VC, New Enterprise Associates, Lux Capital — 27 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$9.4B

Resilience (Blue Ash)'s last reported valuation, Jan 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Resilience (Blue Ash) with a free account
  • ·The complete investor list: 27 names
  • ·Watch Resilience (Blue Ash): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Resilience (Blue Ash) funding rounds

No rounds on record

No funding rounds for Resilience (Blue Ash) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Resilience (Blue Ash) valuation

Resilience (Blue Ash)'s last reported valuation was $9.4 billion in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.

Resilience (Blue Ash) investors

27 investors are on record for Resilience (Blue Ash), including Mubadala Investment Company, GV, 8VC and New Enterprise Associates. By type, the record holds 11 venture capital firms and 2 private equity firms.

About Resilience (Blue Ash)

Operator of a biopharmaceutical manufacturing company intended to change the way medicine is produced. The company offers various customized manufacturing capabilities to serve the requirements of biopharmaceuticals at different stages of the drug development process, from pre-clinical development to commercial supply, ensuring its clients with customized and scalable processes and facilities for complex and novel medicines.

Sector
Healthcare
HQ
Blue Ash, OH, United States
Founded
2020
Employees
1,298
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.